Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

243.04 -1.08 (-0.44%)
Official Closing Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,878,704
Open 245.11
Bid (Size) 242.70 (300)
Ask (Size) 243.00 (300)
Prev. Close 244.12
Today's Range 241.87 - 247.21
52wk Range 141.50 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.14%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
The medical technology sector has long been a bellwether for the health of the broader economy and the efficiency of the healthcare system. Today, April 2, 2026, AngioDynamics (NASDAQ:ANGO) provided... 
Via MarketMinute
Topics Economy Retirement
News headline image
This Healthcare Stock Barely Flinches During Market Sell-Offs ↗
Shares of Johnson & Johnson have fallen by less than 2% over the past month, while the S&P 500 has fallen by more than 7%. 
Via The Motley Fool
Topics Economy Stocks

Performance

YTD
+17.2%
+17.2%
1 Month
-1.5%
-1.5%
3 Month
+17.2%
+17.2%
6 Month
+30.7%
+30.7%
1 Year
+56.4%
+56.4%

More News

Read More
News headline image
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm ↗
Via The Motley Fool
Topics Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Quality Dividend Stock for Reliable Income ↗
Via Chartmill
News headline image
Johnson & Johnson (JNJ) Forecast: Extended Rally Signals Patience for Buyers ↗
Via Talk Markets
News headline image
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation. ↗
Via The Motley Fool
Topics Economy
News headline image
The Dividend King That's Raised Its Payout for 63 Consecutive Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Via Finterra
Topics Lawsuit Product Recall
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is Intuitive Surgical a Buy Right Now? ↗
Via The Motley Fool
Topics World Trade
News headline image
2 Stocks I Plan to Hold for the Next 20 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
A Q2 2026 Playbook for Navigating Market Uncertainty ↗
Via MarketBeat
News headline image
What You Need To Know Ahead of Johnson & Johnson's Earnings Release
Via Barchart.com
Topics ETFs
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
The Fear Gauge Ascendant: VIX Hits 26 as Geopolitical Storms and 'Higher-for-Longer' Reality Grip Markets
Via MarketMinute
Topics Derivatives Economy Stocks
News headline image
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
Via MarketMinute
News headline image
1 Dividend ETF That Could Turn $500 Monthly Into a $725,000 Portfolio That Pays $21,750 Annually ↗
Via The Motley Fool
Topics ETFs
News headline image
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie ↗
Via Benzinga
News headline image
2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
2 Stocks That Could Create Lasting Generational Wealth ↗
Via The Motley Fool
Topics World Trade
News headline image
The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape
Via MarketMinute
Topics Artificial Intelligence Lawsuit

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 243.04
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/02/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 638.87B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 639B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>